REQUEST A DEMO
Total
USD $0.00
Search more companies

Phoenix d.o.o. (Bosnia and Herzegovina)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Phoenix d.o.o. Profile Updated: October 09, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

phoenix pharma bosnia and herzegovina is a company in the healthcare industry. The company specializes in the wholesale of pharmaceutical products and provides logistics support for clinical trials. They deliver over 136,000 boxes of medicines daily in Bosnia and Herzegovina and have been operating in the region since 2015. phoenix pharma bosnia and herzegovina has been present in Bosnia and Herzegovina since 2009 and is a member of the Phoenix Group. They also own the exclusive brand LIVSANE, available in BENU and BETTY pharmacies.

Headquarters
Donja Ljeljenca 15B Str.
Bijeljina; Republic of Srpska; Postal Code: 76300

Contact Details: Purchase the Phoenix d.o.o. report to view the information.

Website: http://www.phoenix.ba

Basic Information
Total Employees:
Purchase the Phoenix d.o.o. report to view the information.
Outstanding Shares:
Purchase the Phoenix d.o.o. report to view the information.
Registered Capital:
Purchase the Phoenix d.o.o. report to view the information.
Incorporation Date:
December 31, 1997
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Subsidiaries
El Pharma d.o.o.
Company Performance
Financial values in the chart are available after Phoenix d.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BAM. Absolute financial data is included in the purchased report.
Net sales revenue
0.91%
Total operating revenue
0.91%
Operating profit (EBIT)
85.43%
EBITDA
46.54%
Net Profit (Loss) for the Period
4.83%
Total assets
-17.5%
Total equity
0.72%
Operating Profit Margin (ROS)
0.7%
Net Profit Margin
0.01%
Return on Equity (ROE)
0.25%
Debt to Equity Ratio
-173.99%
Quick Ratio
0.06%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?